GLP1 Drugs May Benefit Cancer Patients
Over the past few years, the demand for new weight loss medications has skyrocketed, particularly for anti-obesity drugs like semaglutide (Wegovy) and tirzepatide (Zepbound). Known as glucagon-like peptide 1 (GLP-1)